...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: USA ZHCLF investors

Zenith Capital Corporation  75 M shares has nothing to do with Zenith Epigenitics 138 M shares. I have 30,000 shares in Zenith Capitial Corporation and 0 in Zenith Epigentiics. Apples and oranges. This is how I understand it.

 

Share
New Message
Please login to post a reply